First Patient Dosed in Trial of ADCT-402 for Advanced Non-Hodgkin’s Lymphoma
News
A Phase 1 trial testing the combination of ADCT-402 (loncastuximab tesirine) with Imfinzi (durvalumab) in multiple types of advanced non-Hodgkin’s lymphoma has dosed the first patient. The study (NCT03685344) is for adults with ... Read more